Antonino Lupica

Dr. Antonino Lupica

University of Palermo, Palermo, Sicilia, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GSGiuseppe Schirò
Giuseppe Schirò
Vincenzo Di StefanoVincenzo Di Stefano
Vincenzo Di Stefano
SISalvatore Iacono
Salvatore Iacono
ALAntonino Lupica
Antonino Lupica
Filippo BrighinaFilippo Brighina
Filippo Brighina
Carmela BalistreriCarmela Balistreri
Carmela Balistreri
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease, characterized by the progressive degeneration of the upper and lower motor neurons in the cortex and spinal cord. Although the pathogenesis of ALS remains unclear, evidence concerning the role of the clonotypic immune system is growing. Adaptive immunity cells often appear changed in number, or in terms of their activation profiles, both peripherally and centrally; however, their role in ALS appears conflictive. Data from human and animal model studies, which are currently reported in the literature, show that each subset of lymphocytes and their mediators may mediate a protective or toxic mechanism in ALS, affecting both its progression and risk of death. In the present review, an attempt is made to shed light on the actual role of cellular clonotypic immunity in ALS by integrating recent clinical studies and experimental observations.

23 October 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MPMario Pace
Mario Pace
Roberto CannellaRoberto Cannella
Roberto Cannella
Vincenzo Di StefanoVincenzo Di Stefano
Vincenzo Di Stefano
ALAntonino Lupica
Antonino Lupica
PAPaolo Alonge
Paolo Alonge
MGMassimo Galia
Massimo Galia
Autoimmune neuromuscular diseases are a group of heterogenous pathologies secondary to the activation of the immune system that damage the structures of the peripheric nerve, the neuromuscular junction, or the skeleton muscle. The diagnosis of autoimmune neuromuscular disorders comprises a combination of data from clinical, laboratory, electromyography, imaging exam, and biopsy. Particularly, the whole-body MRI examination in the last two decades has been of great use in the assessment of neuromuscular disorders. MRI provides information about the structures involved and the status of activity of the disease. It can also be used as a biomarker, detect the pattern of specific muscle involvement, and is a useful tool for targeting the optimal muscle site for biopsy. In this work, we summarized the most used technical protocol of whole-body MRI and the role of this imaging technique in autoimmune neuromuscular disorders.